Biolinq Inc announced that it will receive $109,511,762 in a round of funding on September 2, 2021. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11,630 KRW | +3.10% |
|
-14.86% | +178.56% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
340 CAD | -.--% | -.--% | 614M | ||
128.6 USD | -0.92% | +1.35% | 6.87B | ||
1st Jan change | Capi. | |
---|---|---|
+178.56% | 256M | |
+75.69% | 12.57B | |
-29.47% | 6.88B | |
+5.26% | 5.02B | |
-19.17% | 4.69B | |
+12.15% | 3.99B | |
-22.33% | 3.65B | |
-22.97% | 2.91B | |
-2.23% | 1.98B | |
+12.99% | 1.82B |
- Stock Market
- Equities
- A294090 Stock
- News EOFLOW Co.,Ltd.
- Biolinq Inc announced that it expects to receive funding